Search results
Added:
3 years ago
The prevalence of heart failure (HF) continues to rise, driven by an ageing population, increasing rates of obesity and diabetes, and better survival in patients with cardiovascular disease.1 While HF is associated with substantial morbidity and mortality, a number of treatments have been shown to improve outcomes in large-scale randomised controlled trials (RCT), including pharmacological…
View more
Added:
1 year ago
Added:
1 year ago
Added:
3 years ago
Hypertension is considered the most common disorder in the general population. It is both a health and a financial problem worldwide. The Writing Group of the American Society of Hypertension defines hypertension as a cardiovascular syndrome resulting from a number of interconnected factors.1 Therefore, a comprehensive evaluation is required, involving both the cardiovascular system and other…
View more
Chan Hong
Job title: Pharmacist
Author
Added:
3 years ago
The specialised role of the heart failure nurse rose to prominence during the 1990s. Studies of heart failure disease management reported a reduction in the risk of hospital readmission in services with structured follow up that focused on the optimisation of therapy, out-patient follow up, education for self-care and the coordination of care.1 Nurses had already established their role in the…
View more
Added:
1 year ago
Added:
3 years ago
Dr Harriette Van Spall and Dr Larry A Allen, principal investigator of the EPIC-HF study discuss the results.
The EPIC-HF study tested the effectiveness of patient engagement using a digital health tool on the optimization of heart failure medication in the ambulatory settings.
Recorded remotely from Aurora and Hamilton, 2020.
Recording Editor: Natascha Wienand
Editor: Mirjam Boros
View more
Added:
3 years ago
Advances in diagnosis and treatment have improved the outlook for the estimated 26 million patients with heart failure (HF) worldwide,1 but there remains a continuing need for further reduction in mortality and hospitalisation and the associated social and financial consequences of the disease. In a European study of outcomes after HF hospitalisation, 17 % of patients died within 12 months and 44…
View more
Added:
3 years ago
Innovative patient-centred interventions are required to improve the self-management of complex, costly and relapsing conditions, such as heart failure (HF). Mobile health (mHealth) technology is a promising tool that could potentially help us reach these goals, but evidence of its clinical benefits and the security of personal health information is still scarce. In view of the increasing number…
View more
